Kohei Wakabayashi, MD; Cedric Delhaye, MD; Michael Mahmoudi, MD; Loic Belle, MD; Itsik Ben-Dor, MD; Michael A. Gaglia, Jr., MD, MSc; William O. Suddath, MD; Lowell F. Satler, MD; Kenneth M. Kent, MD, PhD; Augusto D. Pichard, MD; Joseph Lindsay, MD; Ron Waksman*, MD
Division of Cardiology, Washington Hospital Center, Washington, DC, USA
Aims: The relationship between stent design and periprocedural myocardial infarction is unclear. The newest type of drug-eluting stent (DES), the everolimus-eluting stent (E